Patents by Inventor Jessica Tibasco

Jessica Tibasco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
    Publication number: 20100204273
    Abstract: Disclosed are methods for use of compounds of formula (I) in the treatment of CNS disorders such as dysthymia, schizophrenia, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, pain, and memory disorders: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 12, 2010
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok, Keong Vong, Simon Edward Ward
  • Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
    Patent number: 7732600
    Abstract: Disclosed are methods for the preparation of compounds of formula (I): wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: June 8, 2010
    Assignee: Glaxo Group Limited
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok Keong Vong, Simon Edward Ward
  • QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS
    Publication number: 20090312546
    Abstract: Disclosed are methods for the preparation of compounds of formula (I): wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Application
    Filed: August 13, 2009
    Publication date: December 17, 2009
    Inventors: Markus BERGAUER, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok, Keong Vong, Simon Edward Ward
  • Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
    Patent number: 7592346
    Abstract: Disclosed are methods for use of compounds of formula (I) in combination with other active substances in the treatment of CNS disorders such as depression or anxiety. wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Grant
    Filed: July 2, 2008
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok Keong Vong, Simon Edward Ward
  • Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
    Patent number: 7459456
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: December 2, 2008
    Assignee: Glaxo Group Limited
    Inventors: Matteo Biagetti, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco
  • QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS
    Publication number: 20080280919
    Abstract: Disclosed are methods for use of compounds of formula (I) in combination with other active substances in the treatment of CNS disorders such as depression or anxiety. wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Application
    Filed: July 2, 2008
    Publication date: November 13, 2008
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok Keong Vong, Simon Edward Ward
  • Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
    Patent number: 7279481
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: October 9, 2007
    Assignee: Glaxo Group Limited
    Inventors: Alessandro Falchi, Colin Philip Leslie, Jessica Tibasco
  • QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS
    Publication number: 20070167423
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.
    Type: Application
    Filed: March 16, 2007
    Publication date: July 19, 2007
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Bromidge, Alessandro Falchi, Colin Leslie, Giancarlo Merlo, Domenica Pizzi, Marilisa Rinaldi, Luigi Stasi, Jessica Tibasco, Antonio Vong, Simon Ward
  • Macrolides
    Patent number: 7202221
    Abstract: The present invention relates to 14 or 15 membered macrolides substituted at the 4? position of formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: April 10, 2007
    Assignees: Glaxo Group Limited, Pliva D.D.
    Inventors: Suleman Alihodzic, Daniele Andreotti, Andrea Berdik, Ilaria Bientinesi, Stefano Biondi, Manuela Ciraco, Federica Damiani, Marko Djerek, Miljenko Dumic, Vesna Erakovic, Antun Hutinec, Gorjana Lazarevski, Sergio Lociuro, Natasa Marsic, Zorica Marusic-Istuk, Stjepan Mutak, Alfredo Paio, Drazen Pavlovic, Anna Quaglia, Wolfgang Schoenfeld, Vlado Stimac, Jessica Tibasco
  • Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
    Publication number: 20060229312
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.
    Type: Application
    Filed: July 15, 2004
    Publication date: October 12, 2006
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Bromidge, Alessandro Falchi, Colin Leslie, Giancarlo Merlo, Domenica Pizzi, Marilisa Rinaldi, Luigi Stasi, Jessica Tibasco, Antonio Vong, Simon Ward
  • Macrolide Antibiotics
    Publication number: 20060211636
    Abstract: The present invention relates to 11,12 ? lactone ketolides of formula (I) wherein R, R1, R2, R3 are as defined herein and pharmaceutically acceptable salts and solvates thereof, to process for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.
    Type: Application
    Filed: June 5, 2006
    Publication date: September 21, 2006
    Inventors: Sulejman ALIHODZIC, Daniele Andreotti, Luca Arista, Stefano Biondi, Francesca Cardullo, Manuela Ciraco, Federica Damiani, Sergio Lociuro, Carla Marchioro, Giancarlo Merlo, Anna Mingardi, Daniela Niccolai, Alfredo Paio, Elisabetta Piga, Alfonso Pozzman, Catai Seri, Luca Tarsi, Silvia Terreni, Jessica Tibasco
  • Macrolide antibiotics
    Publication number: 20050215495
    Abstract: The present invention relates to 11,12 ? lactone ketolides of formula (I) wherein R, R1, R2, R3 are as defined herein and pharmaceutically acceptable salts and solvates thereof, to process for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.
    Type: Application
    Filed: May 12, 2005
    Publication date: September 29, 2005
    Inventors: Sulejman Alihodzic, Daniele Andreotti, Luca Arista, Stefano Biondi, Francesca Cardullo, Manuela Ciraco, Federica Damiani, Sergio Lociuro, Carla Marchioro, Giancarlo Merlo, Anna Mingardi, Daniela Niccolai, Alfredo Paio, Elisabetta Piga, Alfonso Pozzan, Catia Seri, Luca Tarsi, Silvia Terreni, Jessica Tibasco
  • Macrolides
    Publication number: 20050080025
    Abstract: The present invention relates to 14 or 15 membered macrolides substituted at the 4th position of formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.
    Type: Application
    Filed: November 13, 2002
    Publication date: April 14, 2005
    Inventors: Suleman Alihodzic, Daniele Andretoh, Andrea Berdik, Ilaria Bientinesi, Stefano Biondi, Manuela Ciraco, Federica Damiani, Marko Djerek, Miljenko Dumic, Vesna Erakovic, Antun Hutinec, Gorjana Lazarevski, Sergio Lociuro, Natasa Marsic, Zorica Marusic-Istuk, Stjepan Mutak, Alfred Paio, Drazen Pavlovic, Anna Quaglia, Wolfgang Schoenfeld, Vlado Stimac, Jessica Tibasco
  • Macrolide antibiotics
    Publication number: 20040077557
    Abstract: The present invention relates to 11,12 &ggr; lactone ketolides of formula (I) wherein R, R1, R2, R3 are as defined herein and pharmaceutically acceptable salts and solvates thereof, to process for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.
    Type: Application
    Filed: November 19, 2003
    Publication date: April 22, 2004
    Inventors: Sulejman Ali, Daniele Andreotti, Luca Arista, Stefano Biondi, Francesca Cardullo, Manuela Ciraco, Federica Damiani, Sergio Lociuro, Carla Marchioro, Giancarlo Merlo, Anna Mingardi, Daniela Niccolai, Alfredo Paio, Elisabetta Piga, Alfonso Pozzan, Catia Seri, Luca Tarsi, Silvia Terreni, Jessica Tibasco